Literature DB >> 16557532

Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats.

Frank Dombrowski1, Clarissa Flaschka, Luisa Klotz, Barbara von Netzer, Carla Schulz, Hendrik Lehnert, Matthias Evert.   

Abstract

Intrahepatic transplantation of ovarian fragments in ovariectomized rats results in morphological abnormalities. The liver acini draining blood from ovarian grafts show alterations resembling chemically induced amphophilic hepatocellular preneoplasias. We investigated the long-term development of these estrogen-induced foci of altered hepatocytes (FAH). We divided 451 Lewis rats into one main group (MG) and 11 (7 female, 4 male) control groups and observed them for up to 30 months. MG animals were ovariectomized and received ovarian transplants into the right liver part. Different combinations of castration, transplantation of ovarian or testicular fragments, and administration of antiestrogenic toremifene were used in controls. In the MG, transplants showed signs of gonadotropic stimulation, and estrogen levels were strongly increased in the downstream liver acini. After 6 and 12 months, FAH developed in hepatocytes downstream of the transplants. After 18 months, 27% of the MG animals showed transformation of FAH into hepatocellular adenomas; this figure increased to 42% after 24 months (8/19), significantly outnumbering four spontaneous adenomas that developed between 18 and 30 months in 258 control animals. Hepatocellular carcinoma (HCC) appeared only in the MG. At 24 and 30 months, 18 HCCs developed; thus, 78% of MG animals showed at least one carcinoma. Administration of toremifene in ovariectomized and transplanted animals completely prevented hepatocarcinogenesis. Testicular grafts showed no influence on liver tissue. In conclusion, initially adaptive but preneoplastic alterations in hepatocytes downstream of intrahepatically transplanted ovarian fragments may transform into HCC, indicating a strong hepatocarcinogenic potential of high local levels of endogenous estrogens in the rat liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557532     DOI: 10.1002/hep.21124

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

Review 1.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

2.  Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report.

Authors:  Aline Hardt; Dirk Stippel; Margarete Odenthal; Arnulf H Hölscher; Hans-Peter Dienes; Uta Drebber
Journal:  Case Rep Pathol       Date:  2012-07-05

3.  Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.

Authors:  Philipp Solbach; Andrej Potthoff; Hans-Jürgen Raatschen; Bisharah Soudah; Ulrich Lehmann; Andrea Schneider; Michael J Gebel; Michael P Manns; Arndt Vogel
Journal:  BMC Gastroenterol       Date:  2015-05-20       Impact factor: 3.067

4.  The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.

Authors:  Silvia Ribback; Verena Sailer; Enrico Böhning; Julia Günther; Jaqueline Merz; Frauke Steinmüller; Kirsten Utpatel; Antonio Cigliano; Kristin Peters; Maria G Pilo; Matthias Evert; Diego F Calvisi; Frank Dombrowski
Journal:  Int J Mol Sci       Date:  2016-09-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.